A Physiotherapy Treatment Plan for Post-COVID-19 Patients That Improves the FEV1, FVC, and 6-Min Walk Values, and Reduces the Sequelae in 12 Sessions

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causal agent of Coronavirus disease 2019 (COVID-19), a pandemic disease declared in 2020. The clinical manifestations of this pathology are heterogeneous including fever, cough, dyspnea, anosmia, headache, fatigue, taste dysfunction...

Full description

Saved in:
Bibliographic Details
Main Authors: Silvia Denise Ponce-Campos (Author), Juan Manuel Díaz (Author), Daniela Moreno-Agundis (Author), Ana Laura González-Delgado (Author), Paulina Andrade-Lozano (Author), Francisco Javier Avelar-González (Author), Eduardo Hernández-Cuellar (Author), Fernando Torres-Flores (Author)
Format: Book
Published: Frontiers Media S.A., 2022-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_e5ea93e5d4cb4ff0a75b658a92cc0fd1
042 |a dc 
100 1 0 |a Silvia Denise Ponce-Campos  |e author 
700 1 0 |a Silvia Denise Ponce-Campos  |e author 
700 1 0 |a Juan Manuel Díaz  |e author 
700 1 0 |a Daniela Moreno-Agundis  |e author 
700 1 0 |a Ana Laura González-Delgado  |e author 
700 1 0 |a Paulina Andrade-Lozano  |e author 
700 1 0 |a Francisco Javier Avelar-González  |e author 
700 1 0 |a Eduardo Hernández-Cuellar  |e author 
700 1 0 |a Fernando Torres-Flores  |e author 
245 0 0 |a A Physiotherapy Treatment Plan for Post-COVID-19 Patients That Improves the FEV1, FVC, and 6-Min Walk Values, and Reduces the Sequelae in 12 Sessions 
260 |b Frontiers Media S.A.,   |c 2022-05-01T00:00:00Z. 
500 |a 2673-6861 
500 |a 10.3389/fresc.2022.907603 
520 |a Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causal agent of Coronavirus disease 2019 (COVID-19), a pandemic disease declared in 2020. The clinical manifestations of this pathology are heterogeneous including fever, cough, dyspnea, anosmia, headache, fatigue, taste dysfunction, among others. Survivors of COVID-19 have demonstrated several persistent symptoms derived from its multisystemic physiopathology. These symptoms can be fatigue, dyspnea, chest pain, dry and productive cough, respiratory insufficiency, and psychoemotional disturbance. To reduce and recover from the post-COVID-19 sequelae is fundamental an early and multifactorial medical treatment. Integral post-COVID-19 physiotherapy is a tool to reduce dyspnea, improve lung capacity, decrease psychoemotional alterations, as well as increase the muscle strength affected by this disease. Thus, the aim of this study was to establish a novel physiotherapeutic plan for post-COVID-19 patients, evaluating the effect of this treatment in the reduction of the sequelae in terms of lung capacity, cardio-respiratory, and muscular strength improvements. This was a cross-sectional study in which a protocol of 12 sessions in 4 weeks of physiotherapy was implemented in the patients enrolled. We conducted a medical assessment, an interview, a DASS-21 test, a spirometry, a 6-min walk test, and a hand dynamometer test to evaluate the post-COVID condition of patients before and after the sessions. A total of 42 patients participated in the program. Results of this work showed a decrease of around 50% of post-COVID-19 sequelae and an improvement in the psychoemotional status of patients. Also, we observed an increase of 7.16% in the FEV1 value and 7.56% for FVC. In addition, the maximal functional capacity increased by 0.577 METs, the 6-min walk test performance increased by 13%, and the SpO2 improved by 1.40%. Finally, the handgrip strength test showed an improvement in the left hand and right hand of 2.90 and 2.24 Kg, respectively. We developed this study to propose a novel methodology to provide information for a better treatment and management of post-COVID-19 patients. 
546 |a EN 
690 |a post-COVID-19 
690 |a respiratory function 
690 |a physiotherapy 
690 |a 6-min walk test 
690 |a SARS-CoV-2 
690 |a spirometry 
690 |a Other systems of medicine 
690 |a RZ201-999 
690 |a Medical technology 
690 |a R855-855.5 
655 7 |a article  |2 local 
786 0 |n Frontiers in Rehabilitation Sciences, Vol 3 (2022) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fresc.2022.907603/full 
787 0 |n https://doaj.org/toc/2673-6861 
856 4 1 |u https://doaj.org/article/e5ea93e5d4cb4ff0a75b658a92cc0fd1  |z Connect to this object online.